文献速递肝病

原发性硬化性胆管炎与自身免疫性肝炎重叠特征:成熟还是年龄歧视问题?

Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: A coming of age or an age-ist problem?
PubMed 文献 · J Hepatol · 2023-03-03

自身免疫性肝病被分为三种临床综合征,但变异表现常挑战这些分类。本文论述自身免疫性硬化性胆管炎(ASC)与PSC/AIH重叠并非独立疾病实体,而是PSC的炎症阶段,常在病程早期(尤其年轻患者)出现,最终结局与经典PSC表型相似,故主张统一疾病命名以促进协作研究和治疗进展。

要点

  • ASC与PSC/AIH重叠并非独立疾病实体,而是PSC的炎症阶段。
  • 这些炎症阶段常在病程早期出现,尤其见于年轻患者。
  • 最终疾病结局与晚年观察到的经典PSC表型相似。

核心结论

  • ASC与PSC/AIH重叠不是独立疾病实体,而是PSC的炎症阶段,常在病程早期尤其年轻患者中表现,最终结局与经典PSC表型相似。
  • 作者主张统一所有患者亚群中临床医生使用的疾病名称和描述,以帮助统一诊疗。

研究设计与样本

  • 本文为论述性文章,基于对自身免疫性肝病分类及PSC/AIH重叠概念的讨论。

主要发现

  • 自身免疫性肝病被分为三种临床综合征,但变异表现挑战这些分类,分类前提是缺乏可定义病因。
  • 临床医生遇到同时具有PSC和AIH常见生化、血清学和组织学表现的个体,常标记为「PSC/AIH重叠」。
  • 儿童期可使用「自身免疫性硬化性胆管炎(ASC)」一词,部分人认为其是独立疾病过程。
  • 作者认为ASC与PSC/AIH重叠并非独立实体,而是PSC的炎症阶段,常在病程早期尤其年轻患者中表现。
  • 最终疾病结局与晚年观察到的经典PSC表型相似。

临床怎么用

  • 作者主张统一所有患者亚群中临床医生使用的疾病名称和描述,以帮助统一诊疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autoimmune liver diseases are siloed into three syndromes that define clinical practice. These classifiers can, and are, challenged by variant presentations across all ages, something inevitable to disease definitions that rely on interpreting (inherently variable) semi-quantitative/qualitative clinical, laboratory, pathological or radiological findings. Furthermore this categorisation is premised on an ongoing absence of definable disease aetiologies. Clinicians thus encounter individuals with biochemical, serological, and histological manifestations that are common to both primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH), often labelled as 'PSC/AIH-overlap'. In childhood the term 'autoimmune sclerosing cholangitis (ASC)' may be used, and some propose this to be a distinct disease process. In this article we champion the concept that ASC and PSC/AIH-overlap are not distinct entities. Rather, they represent inflammatory phases of PSC frequently manifesting earlier in the disease course, most notably in younger patients. Ultimately, disease outcomes remain similar to those of a more classical PSC phenotype observed in later life. Thus, we argue that it is now time to align disease names and descriptions used by clinicians across all patient subpopulations, to help unify care. This will enhance collaborative studies and ultimately contribute to rational treatment advances.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Ricciuto A, Kamath BM, Hirschfield GM, et al. Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: A coming of age or an age-ist problem? J Hepatol. 2023. PMID: 36870613. doi:10.1016/j.jhep.2023.02.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。